Abstract
The recent development and clinical success of molded recombinant collagen corneal substitutes offers a tantalizing prospect for the application of additive biomanufacturing in corneal tissue engineering and regenerative medicine (TERM). The cornea has a number of advantages over other tissues for additive biomanufacturing in that it is relatively homogeneous and completely avascular and has low metabolic demand. Additive biomanufacturing could bring a number of advantages over molding to corneal TERM, including increased visual acuity and mechanical strength. We have developed a method for producing thin collagen films, which are suitable for the culturing of corneal mesenchymal stem cells (MSCs), using additive manufacturing techniques, and we hope to use this technique to produce functional corneal substitutes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
